Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and literature review

Preclinical cases suggest that EGFR tyrosine kinase inhibitors (TKIs) plus MET TKIs are a potential therapy for non-classical EGFR mutant lung cancers with MET amplification acquired resistance. Herein, we report for the first time the effectiveness of novel combination treatment regimens for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yun, Su, Cuiyun, Shi, Lina, Luo, Wenqi, Liu, Zhen, Liang, Chuqiao, Wang, Huilin, Ning, Ruiling, Yu, Qitao, Jiang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992534/
https://www.ncbi.nlm.nih.gov/pubmed/36910616
http://dx.doi.org/10.3389/fonc.2023.1126325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992534/
https://www.ncbi.nlm.nih.gov/pubmed/36910616
http://dx.doi.org/10.3389/fonc.2023.1126325

Ejemplares similares